Citations (244)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (20)
Yanpo Si, Chengcheng Hui, Tao Guo, Mengqi Liu, Xiaohui Chen, Chunhong Dong & Shuying Feng. (2023) Phellodendronoside A Exerts Anticancer Effects Depending on Inducing Apoptosis Through ROS/Nrf2/Notch Pathway and Modulating Metabolite Profiles in Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma 10, pages 935-948.
Read now
Read now
Shuqin Wu, Baoshan Zhong, Yuxin Yang, Yurou Wang & Zezheng Pan. (2023) ceRNA networks in gynecological cancers progression and resistance. Journal of Drug Targeting 31:9, pages 920-930.
Read now
Read now
Zhilong Chen, Zhen Xu, Qian Wang, Lu Wang, Hailing Zhang, Wuliang Wang, Hu Zhao, Yilin Guo & Jinquan Cui. (2023) Exosome-delivered circRNA circSYT15 contributes to cisplatin resistance in cervical cancer cells through the miR-503-5p/RSF1 axis. Cell Cycle 22:20, pages 2211-2228.
Read now
Read now
Dayanand Swami, Priyanka Mudaliar, Yash Shrinivas Bichu, Vishal Kumar Sahu, Shine Devarajan, Soumya Basu & Jyotirmoi Aich. (2023) Synergistic combination of ritonavir and cisplatin as an efficacious therapy in human cervical cancer cells: a computational drug discovery and in vitro insight. Journal of Biomolecular Structure and Dynamics 41:12, pages 5802-5816.
Read now
Read now
Taha Koray Sahin, Birdal Bilir & Omer Kucuk. (2023) Modulation of inflammation by phytochemicals to enhance efficacy and reduce toxicity of cancer chemotherapy. Critical Reviews in Food Science and Nutrition 63:15, pages 2494-2508.
Read now
Read now
Lixia Wu, Jing Gao, Subin Liu, Yuling Jia, Cairan Li & Lihong Duan. (2022) CircRNA circ_0005273 contributes to the cisplatin resistance of cervical cancer cells by sponging miR-133b. Journal of Obstetrics and Gynaecology 42:7, pages 3086-3093.
Read now
Read now
Wenbin Xu, Shangdan Xie, Xin Chen, Shuya Pan, Hongfei Qian & Xueqiong Zhu. (2021) Effects of Quercetin on the Efficacy of Various Chemotherapeutic Drugs in Cervical Cancer Cells. Drug Design, Development and Therapy 15, pages 577-588.
Read now
Read now
Xiangxun Chen, Mengxi Zhou, Wenjie Fan, Mingwei Yang & Lin Yang. (2021) Combination of Sodium Cantharidinate with Cisplatin Synergistically Hampers Growth of Cervical Cancer. Drug Design, Development and Therapy 15, pages 171-183.
Read now
Read now
Soghra Bagheri & Ali A. Saboury. (2021) Hypothesis of using albumin to improve drug efficacy in cancers accompanied by hypoalbuminemia. Xenobiotica 51:7, pages 778-785.
Read now
Read now
Bofei Wang, Jing Hang, Weiling Li & Wanqiong Yuan. (2020) Knockdown of LncRNA DLEU2 Inhibits Cervical Cancer Progression via Targeting miR-128-3p. OncoTargets and Therapy 13, pages 10173-10184.
Read now
Read now
Sadia Sarwar, Jun Qing Yu, Humaira Nadeem & Fazlul Huq. (2020) Synergistic Cytotoxic Effect from Combination of Wedelolactone and Cisplatin in HeLa Cell Line: A Novel Finding. Drug Design, Development and Therapy 14, pages 3841-3852.
Read now
Read now
Min Lin, Chunyu Pan, Wenbin Xu, Jingwei Li & Xueqiong Zhu. (2020) Leonurine Promotes Cisplatin Sensitivity in Human Cervical Cancer Cells Through Increasing Apoptosis and Inhibiting Drug-Resistant Proteins. Drug Design, Development and Therapy 14, pages 1885-1895.
Read now
Read now
Reem N Hassan, Hualei Luo & Weiying Jiang. (2020) Effects of Nicotinamide on Cervical Cancer-Derived Fibroblasts: Evidence for Therapeutic Potential. Cancer Management and Research 12, pages 1089-1100.
Read now
Read now
Shanshan Zhao, Mingxin Yu & Lei Wang. (2020) LncRNA miR503HG Regulates the Drug Resistance of Recurrent Cervical Squamous Cell Carcinoma Cells by Regulating miR-155/Caspase-3. Cancer Management and Research 12, pages 1579-1585.
Read now
Read now
Shahin Aghamiri, Sam talaei, Soheil Roshanzamiri, Farshid Zandsalimi, Elnaz Fazeli, Mansur Aliyu, Omid Kheiry Avarvand, Zahra Ebrahimi, Mahsa Keshavarz-Fathi & Hossein Ghanbarian. (2020) Delivery of genome editing tools: A promising strategy for HPV-related cervical malignancy therapy. Expert Opinion on Drug Delivery 17:6, pages 753-766.
Read now
Read now
Hai Xu, Yuan Sun, Lan Zeng, Ying Li, Shan Hu, Shuping He, Haixia Chen, Qing Zou & Baoping Luo. (2019) Inhibition of cytosolic phospholipase A2 alpha increases chemosensitivity in cervical carcinoma through suppressing β-catenin signaling. Cancer Biology & Therapy 20:6, pages 912-921.
Read now
Read now
Donatella Vizza, Simona Lupinacci, Giuseppina Toteda, Francesco Puoci, Parisi Ortensia I, Anna De Bartolo, Danilo Lofaro, Luca Scrivano, Renzo Bonofiglio, Antonella La Russa, Martina Bonofiglio & Anna Perri. (2019) An Olive Leaf Extract Rich in Polyphenols Promotes Apoptosis in Cervical Cancer Cells by Upregulating p21Cip/WAF1 Gene Expression. Nutrition and Cancer 71:2, pages 320-333.
Read now
Read now
Chuchu Zhao, Ermei Lu, Xiaoli Hu, Huihui Cheng, Jian-An Zhang & Xueqiong Zhu. (2018) S100A9 regulates cisplatin chemosensitivity of squamous cervical cancer cells and related mechanism. Cancer Management and Research 10, pages 3753-3764.
Read now
Read now
Chenzhe Feng, Fang Ma, Chunhong Hu, Jin-an Ma, Jingjing Wang, Yang Zhang, Fang Wu, Tao Hou, Shun Jiang, Yapeng Wang & Yeqian Feng. (2018) SOX9/miR-130a/CTR1 axis modulates DDP-resistance of cervical cancer cell. Cell Cycle 17:4, pages 448-458.
Read now
Read now
Shijie Wu, Ting Luo, Xiaoyong Lei & Xiaoyan Yang. Emerging role of competing endogenous RNA in lung cancer drug resistance. Journal of Chemotherapy 0:0, pages 1-20.
Read now
Read now
Articles from other publishers (224)
Jiaqi Li, Siyi Chen, Junsong Wu, Xuefeng Liu, Hejing Liu, Yuedong Liu & Zhuoying Zhu. (2023) Pathogenomics model for personalized medicine in cervical cancer: Cross‐talk of gene expressions and pathological images related to oxidative stress. Environmental Toxicology 39:2, pages 751-767.
Crossref
Crossref
Yiwen Wang, Chen Lou, Siyuan Zhao, Binfen Li, Youli Zhang, Zhecheng Yu, Fangfang Wu, Daqing Chen & Qian Wu. (2024) Preparation of polypeptide-metal complexes-coated Hosenkoside A and its inhibitory effect in cervical cancer. International Journal of Biological Macromolecules, pages 129177.
Crossref
Crossref
Matteo Nadile, Amanda Kornel, Newman Siu Kwan Sze & Evangelia Tsiani. (2023) A Comprehensive Review of Genistein’s Effects in Preclinical Models of Cervical Cancer. Cancers 16:1, pages 35.
Crossref
Crossref
Rui Fu, Borui Zhao, Min Chen, Xiaolong Fu, Qian Zhang, Yange Cui, Xin Hu & Wei Zhou. (2023) Moving beyond cisplatin resistance: mechanisms, challenges, and prospects for overcoming recurrence in clinical cancer therapy. Medical Oncology 41:1.
Crossref
Crossref
Leila Farhoudi, Seth-Frerich Fobian, Arlene L. Oei, Mohamadreza Amin, Mahmoud Reza Jaafari & Timo L.M. ten Hagen. (2023) Applications of biomimetic nanoparticles in breast cancer as a blueprint for improved next-generation cervical cancer therapy. Nano Today 53, pages 102032.
Crossref
Crossref
Gian Carlo D´Angelo de Queiroz, Fernanda Carolina Ribeiro Dias, Sandra Maria de Torres, Márcia de Figueiredo Pereira, Danielle Barbosa Morais, Wagner Eduardo da Silva & Valdemiro Amaro da Silva Junior. (2023) Bioconjugate based on cisplatin and bacterial exopolysaccharide with reduced side effects: A novel proposal for cancer treatment. Journal of Trace Elements in Medicine and Biology, pages 127374.
Crossref
Crossref
Miaomiao Ye, Tingxian Liu, Liqing Miao, Shuangwei Zou, Huihui Ji, Jian’an Zhang & Xueqiong Zhu. (2023) The Role of ZNF275/AKT Pathway in Carcinogenesis and Cisplatin Chemosensitivity of Cervical Cancer Using Patient-Derived Xenograft Models. Cancers 15:23, pages 5625.
Crossref
Crossref
Ritu Raina, Arif Hussain, Abdulmajeed G. Almutary, Shafiul Haque, Tasleem Raza, Ashley Cletus D’Souza, Sachin Subramani & Akash Sajeevan. (2023) Co-administration of Chrysin and Luteolin with Cisplatin and Topotecan Exhibits a Variable Therapeutic Value in Human Cancer Cells, HeLa. ACS Omega 8:44, pages 41204-41213.
Crossref
Crossref
Xingliang Tan, Yanjun Wang, Zhiming Wu, Qianghua Zhou, Yi Tang, Zhicheng Liu, Gangjun Yuan, Sihao Luo, Yuantao Zou, Shengjie Guo, Na Han & Kai Yao. (2023) The role of Her-2 in penile squamous cell carcinoma progression and cisplatin chemoresistance and potential for antibody-drug conjugate-based therapy. European Journal of Cancer 194, pages 113360.
Crossref
Crossref
Peng Xing, Shuo Wang, Yu Cao, Bo Liu, Feifei Zheng, Wei Guo, Junhao Huang, Zimo Zhao, Ziyi Yang, Xingda Lin, Liang Sang & Zhe Liu. (2023) Treatment strategies and drug resistance mechanisms in adenocarcinoma of different organs. Drug Resistance Updates 71, pages 101002.
Crossref
Crossref
Teng Ma, Jianxin Guo, Jian Han, Lanfang Li, Yifei Ren, Jie Huang, Ge Diao, Xiuhui Zheng & Yingru Zheng. (2023) Circ_0001589/miR‐1248/HMGB1 axis enhances EMT‐mediated metastasis and cisplatin resistance in cervical cancer. Molecular Carcinogenesis 62:11, pages 1645-1658.
Crossref
Crossref
Madita Wandrey, Jadwiga Jablonska, Roland H. Stauber & Désirée Gül. (2023) Exosomes in Cancer Progression and Therapy Resistance: Molecular Insights and Therapeutic Opportunities. Life 13:10, pages 2033.
Crossref
Crossref
Ruipu Chen, Tingyu Fang, Na Liu, Xuejiao Shi, Junsen Wang & Huaping Yu. (2023) Transglutaminase 3 suppresses proliferation and cisplatin resistance of cervical cancer cells by inactivation of the PI3K/AKT pathway. Naunyn-Schmiedeberg's Archives of Pharmacology.
Crossref
Crossref
Noushin Modabber, Sarah Sadat Mahboub, Sahar Khoshravesh, Fatemeh Karimpour, Anita Karimi & Vahid Goodarzi. (2023) Evaluation of Long Non-coding RNA (LncRNA) in the Pathogenesis of Chemotherapy Resistance in Cervical Cancer: Diagnostic and Prognostic Approach. Molecular Biotechnology.
Crossref
Crossref
Mai A. Abd-Elmawla, Sherif S. Abdel Mageed, Tohada M. AL-Noshokaty, Mohammed S. Elballal, Ahmed I. Abulsoud, Shereen Saeid Elshaer, Ahmed A. El-Husseiny, Doaa Fathi, Heba M. Midan, Nehal I. Rizk, Mahmoud A. Elrebehy, Ghadir A. Sayed, Manar Mohammed El Tabaa, Aya Salman, Osama A. Mohammed, Alaa Ashraf, Emad Gamil Khidr, Reem Khaled, Walaa A. El-Dakroury, Gouda Kamel Helal, Yasser M. Moustafa & Ahmed S. Doghish. (2023) Melodic maestros: Unraveling the role of miRNAs in the diagnosis, progression, and drug resistance of malignant pleural mesothelioma. Pathology - Research and Practice 250, pages 154817.
Crossref
Crossref
John Kessellie Jallah, Ashish Anjankar & Francis A Nankong. (2023) Public Health Approach in the Elimination and Control of Cervical Cancer: A Review. Cureus.
Crossref
Crossref
Safoora Pordel, Motahare Khorrami, Fatemeh Saadatpour, Delsuz Rezaee, William C. Cho, Saleheh Jahani, Seyed Mohsen Aghaei-Zarch, Elham Hashemi & Sajad Najafi. (2023) The role of microRNA-185 in the pathogenesis of human diseases: A focus on cancer. Pathology - Research and Practice 249, pages 154729.
Crossref
Crossref
Shama Parveen, Shireen Masood, Saurabh Kumar & Monisha Banerjee. (2023) Phytonanomedicine: A therapeutic approach for cervical cancer. OpenNano 13, pages 100178.
Crossref
Crossref
Zeinab Mokhtari, Effat Seyedhashemi, Maryam Eftekhari, Shiva Ghasemi, Akram Sabouri, Kazem Abbaszadeh-Goudarzi, Morteza Abuali, Hanie Azimi, Prashant Kesharwani, Hossein Pourghadamyari & Amirhossein Sahebkar. (2023) Enhancement of cisplatin-induced apoptosis by saffron in human lung cancer cells. Journal of Trace Elements in Medicine and Biology 79, pages 127229.
Crossref
Crossref
Patricia Hannon Barroeta, Maureen J. O’Sullivan & Daniela M. Zisterer. (2023) The role of the Nrf2/GSH antioxidant system in cisplatin resistance in malignant rhabdoid tumours. Journal of Cancer Research and Clinical Oncology 149:11, pages 8379-8391.
Crossref
Crossref
James A. Scarth, Christopher W. Wasson, Molly R. Patterson, Debra Evans, Diego Barba-Moreno, Holli Carden, Rosa Cassidy, Adrian Whitehouse, Jamel Mankouri, Adel Samson, Ethan L. Morgan & Andrew Macdonald. (2023) Exploitation of ATP-sensitive potassium ion (KATP) channels by HPV promotes cervical cancer cell proliferation by contributing to MAPK/AP-1 signalling. Oncogene 42:34, pages 2558-2577.
Crossref
Crossref
Elmira Babakanrad, Taher Mohammadian, Davoud Esmaeili & Payam Behzadi. (2023) Cervical Cancer: A Review of Epidemiology, Treatments and Anticancer
Drugs. Current Cancer Therapy Reviews 19:3, pages 198-212.
Crossref
Crossref
Xiangyu Tan, Xueqian Wang, Xueyao Liao, Xin Wang, Zhichao Jiang, Wenjia Liang, Chen Cao, Danni Gong, Zheng Hu & Xun Tian. (2023) Downregulation of VPS13C promotes cisplatin resistance in cervical cancer by upregulating GSTP1. iScience 26:8, pages 107315.
Crossref
Crossref
Radhakrishnan Kartikeyan, Dhanashree Murugan, Tamilarasan Ajaykamal, Manikandan Varadhan, Loganathan Rangasamy, Marappan Velusamy, Mallayan Palaniandavar & Venugopal Rajendiran. (2023)
Mixed ligand copper(
ii
)-diimine complexes of 2-formylpyridine-
N
4
-phenylthiosemicarbazone: diimine co-ligands tune the
in vitro
nanomolar cytotoxicity
. Dalton Transactions 52:26, pages 9148-9169.
Crossref
Crossref
Sangavi Eswaran, Mythili Padavu, Dileep Kumar & Shama Prasada Kabekkodu. (2023) Systematic Analysis of the Therapy Resistance Genes and their Prognostic
Relevance in Cervical Cancer. Current Pharmaceutical Design 29:25, pages 2018-2032.
Crossref
Crossref
Wangie Yu, Yunyun Chen, Nagireddy Putluri, Abdullah Osman, Cristian Coarfa, Vasanta Putluri, Abu H. M. Kamal, Jennifer Kay Asmussen, Panagiotis Katsonis, Jeffrey N. Myers, Stephen Y. Lai, Wuhao Lu, Clifford C. Stephan, Reid T. Powell, Faye M. Johnson, Heath D. Skinner, Jawad Kazi, Kazi Mokim Ahmed, Linghao Hu, Addison Threet, Matthew D. Meyer, James A. Bankson, Tony Wang, Jack Davis, Kirby R. Parker, Madison A. Harris, Mokryun L. Baek, Gloria V. Echeverria, Xiaoli Qi, Jin Wang, Andy I. Frederick, Alex J. Walsh, Olivier Lichtarge, Mitchell J. Frederick & Vlad C. Sandulache. (2023) Evolution of cisplatin resistance through coordinated metabolic reprogramming of the cellular reductive state. British Journal of Cancer 128:11, pages 2013-2024.
Crossref
Crossref
Xin Wang, Chen Cao, Xiangyu Tan, Xueyao Liao, Xiaofang Du, Xueqian Wang, Ting Liu, Danni Gong, Zheng Hu & Xun Tian. (2023) SETD8, a frequently mutated gene in cervical cancer, enhances cisplatin sensitivity by impairing DNA repair. Cell & Bioscience 13:1.
Crossref
Crossref
Weijia Wang & Nan Zhang. (2023) Oridonin inhibits Hela cell proliferation via downregulation of glutathione metabolism: a new insight from metabolomics. Journal of Pharmacy and Pharmacology 75:6, pages 837-845.
Crossref
Crossref
Takashiro Akitsu, Dobrina Tsvetkova, Yuma Yamamoto, Daisuke Nakane & Irena Kostova. (2023) From Basics of Coordination Chemistry to Understanding Cisplatin-analogue Pt
Drugs. Current Pharmaceutical Design 29:22, pages 1747-1774.
Crossref
Crossref
N. N. Shen, J. H. Lin & P. P. Liu. (2023) EBF1 Promotes the Sensitivity of Cervical Cancer Cells to Cisplatin via Activating FBN1 Transcription. Molecular Biology 57:3, pages 491-501.
Crossref
Crossref
Se Jin Oh, Ji Yeon Lim, Min Kyu Son, Jun Hyeok Ahn, Kwon-Ho Song, Hyo-Jung Lee, Suyeon Kim, Eun Ho Cho, Joon-Yong Chung, Hanbyoul Cho, Hyosun Kim, Jae-Hoon Kim, Jooyoung Park, Jungmin Choi, Sun Wook Hwang & Tae Woo Kim. (2023) TRPV1 inhibition overcomes cisplatin resistance by blocking autophagy-mediated hyperactivation of EGFR signaling pathway. Nature Communications 14:1.
Crossref
Crossref
Yu Wang, Kunfeng Xie, Wei Chen, Yunze Fang, Qixin Mo, Henghui Zhang, Xinlei Zhao, Dongqing Li, Wanlong Tan, Peng Zhao & Fei Li. (2023) Synergistic ferroptosis‐starvation therapy for bladder cancer based on hyaluronic acid modified metal–organic frameworks. Bioengineering & Translational Medicine 8:3.
Crossref
Crossref
Ishrat Khan, R Harshithkumar, Ashwini More & Anupam Mukherjee. (2023) Human Papilloma Virus: An Unraveled Enigma of Universal Burden of Malignancies. Pathogens 12:4, pages 564.
Crossref
Crossref
Sisi Deng, Lili Qian, Luwen Liu, Hanyuan Liu, Zhihao Xu, Yujie Liu, Yingying Wang, Liang Chen & Ying Zhou. (2023)
Circular RNA ARHGAP5
inhibits cisplatin resistance in cervical squamous cell carcinoma by interacting with
AUF1
. Cancer Science 114:4, pages 1582-1595.
Crossref
Crossref
Monserrat Carrera‐Martínez, María de L. Mora‐García, Rosario García‐Rocha, Benny Weiss‐Steider, Juan J. Montesinos‐Montesinos, Jorge Hernández‐Montes, Christian A. Don‐López & Alberto Monroy‐García. (2023) Inhibition of CD73 expression or A2AR blockade reduces MRP1 expression and increases the sensitivity of cervical cancer cells to cisplatin. Cell Biochemistry and Function 41:3, pages 321-330.
Crossref
Crossref
Juan Jin, Jianing Cao, Bin Li, Ting Li, Jian Zhang, Jun Cao, Mingchun Zhao, Leiping Wang, Biyun Wang, Zhonghua Tao & Xichun Hu. (2023) Landscape of DNA damage response gene alterations in breast cancer: A comprehensive investigation. Cancer 129:6, pages 845-859.
Crossref
Crossref
Wen-Ying Shen, Chun-Peng Jia, Li-Yi Liao, Liu-Lin Chen, Cheng-Cheng Yuan, Yun-Qiong Gu, Yang-Han Liu, Hong Liang & Zhen-Feng Chen. (2023)
Copper(
ii
) complex enhanced chemodynamic therapy through GSH depletion and autophagy flow blockade
. Dalton Transactions 52:11, pages 3287-3294.
Crossref
Crossref
Shijie Yao, Liyang Zhao, Siming Chen, Hua Wang, Yang Gao, Ning-Yi Shao, Mengyuan Dai & Hongbing Cai. (2023) Cervical cancer immune infiltration microenvironment identification, construction of immune scores, assisting patient prognosis and immunotherapy. Frontiers in Immunology 14.
Crossref
Crossref
Nazia AFROZE, Madhumitha K. SUNDARAM, Ritu RAINA, Jasmine JATHAN, Deepika BHAGAVATULA, Shafiul HAQUE & Arif HUSSAIN. (2023) Concurrent treatment of flavonol with chemotherapeutics potentiates or counteracts the therapeutic implications in cervical cancer cells. Minerva Biotechnology and Biomolecular Research 35:1.
Crossref
Crossref
Ye Wei, Shitong Lin, Wenhua Zhi, Tian Chu, Binghan Liu, Ting Peng, Miaochun Xu, Wencheng Ding, Canhui Cao & Peng Wu. (2023)
Genomic analysis of cervical carcinoma identifies Alpelisib as a therapeutic option for
PIK3CA
‐mutant cervical carcinoma via the PI3K/AKT pathway
. Journal of Medical Virology 95:3.
Crossref
Crossref
Ruijing Feng, Xin Wang, Hongwei Chen, Chen Cao, Ting Liu, Tong Zhao, Huang Chen, Rui Tian, Yangyang Ni, Xun Tian, Zheng Hu, Ji Ma & Danni Gong. (2023) Knockdown of PRKD2 Enhances Chemotherapy Sensitivity in Cervical
Cancer via the TP53/CDKN1A Pathway. Current Cancer Drug Targets 23:2, pages 159-170.
Crossref
Crossref
Giovanni Tossetta & Daniela Marzioni. (2023) Targeting the NRF2/KEAP1 pathway in cervical and endometrial cancers. European Journal of Pharmacology 941, pages 175503.
Crossref
Crossref
Yueyan Li, Xuan Huang & Jing Tang. (2023) Inhibiting the growth of ovarian cancer cells in vitro and in vivo by a small molecular inhibitor targeting La-RNA interactions. European Journal of Pharmacology 940, pages 175471.
Crossref
Crossref
Xiaoli Liu, Junhua Zhang, Shuang Ju, Lu Liu, Yu Sun, Lingyu Guo, Qianwei Zhen, Sai Han, Wei Lu & Youzhong Zhang. (2022) ECT2 promotes malignant phenotypes through the activation of the AKT/mTOR pathway and cisplatin resistance in cervical cancer. Cancer Gene Therapy 30:1, pages 62-73.
Crossref
Crossref
Yumin Wang, Xiaorui Wu, Zhao Ren, Yulin Li, Wailong Zou, Jichao Chen & Hongquan Wang. (2023) Overcoming cancer chemotherapy resistance by the induction of ferroptosis. Drug Resistance Updates 66, pages 100916.
Crossref
Crossref
Velmurugan Devadasan, K. Abinaya, R. Muthezhilan, K. Puviarasan & Pachaiappan Raman. 2023. Phospholipases in Physiology and Pathology. Phospholipases in Physiology and Pathology
197
216
.
Yuna Cho, Yun-Jeong Jeong, Kwon-Ho Song, Il-Kyung Chung, Junji Magae, Taeg Kyu Kwon, Yung-Hyun Choi, Jong-Young Kwak & Young-Chae Chang. (2022) 4-O-Methylascochlorin-Mediated BNIP-3 Expression Controls the Balance of Apoptosis and Autophagy in Cervical Carcinoma Cells. International Journal of Molecular Sciences 23:23, pages 15138.
Crossref
Crossref
Brigida Anna Maiorano, Mauro Francesco Pio Maiorano, Davide Ciardiello, Annamaria Maglione, Michele Orditura, Domenica Lorusso & Evaristo Maiello. (2022) Beyond Platinum, ICIs in Metastatic Cervical Cancer: A Systematic Review. Cancers 14:23, pages 5955.
Crossref
Crossref
Dan WEN, Li WANG, Songhong TAN, Rong TANG, Weimin XIE, Shanyan LIU, Caixia TANG & Yingxin HE. (2022) HOXD9 aggravates the development of cervical cancer by transcriptionally activating HMCN1. Panminerva Medica 64:4.
Crossref
Crossref
Irene A. George, Richa Chauhan, R.E. Dhawale, Roshini Iyer, Sewanti Limaye, R. Sankaranarayanan, R. Venkataramanan & Prashant Kumar. (2022) Insights into therapy resistance in cervical cancer. Advances in Cancer Biology - Metastasis 6, pages 100074.
Crossref
Crossref
Ranadip Mandal, Monika Raab, Franz Rödel, Andrea Krämer, Izabela Kostova, Samuel Peña-Llopis, Gioele Medici, Björn Häupl, Thomas Oellerich, Khayal Gasimli, Mourad Sanhaji, Sven Becker & Klaus Strebhardt. (2022) The non-apoptotic function of Caspase-8 in negatively regulating the CDK9-mediated Ser2 phosphorylation of RNA polymerase II in cervical cancer. Cellular and Molecular Life Sciences 79:12.
Crossref
Crossref
En Yuesu Wu, Li‐Ping Huang & Jin‐Hua Bao. (2022)
miR
‐96‐5p regulates cervical cancer cell resistance to cisplatin by inhibiting
lncRNA TRIM52‐AS1
and promoting
IGF2BP2
. The Kaohsiung Journal of Medical Sciences 38:12, pages 1178-1189.
Crossref
Crossref
Jeong Han, Ha-Yeon Song, Kwang-Il Kim, Woo Park, Sang-Hyun Park, Eui-Baek Byun & Eui-Hong Byun. (2022)
Polysaccharides from
Annona muricata
leaves protect against cisplatin‑induced cytotoxicity in macrophages by alleviating mitochondrial dysfunction
. Molecular Medicine Reports 27:1.
Crossref
Crossref
Emad A. Ahmed, Hamad Abu Zahra, Rebai Ben Ammar, Maged Elsayed Mohamed & Hairul-Islam M. Ibrahim. (2022) Beta-Caryophyllene Enhances the Anti-Tumor Activity of Cisplatin in Lung Cancer Cell Lines through Regulating Cell Cycle and Apoptosis Signaling Molecules. Molecules 27:23, pages 8354.
Crossref
Crossref
Qian Sun, Liangliang Wang, Cong Zhang, Zhenya Hong & Zhiqiang Han. (2022) Cervical cancer heterogeneity: a constant battle against viruses and drugs. Biomarker Research 10:1.
Crossref
Crossref
Jin Gao, Yadong Li, Xiaoteng Zou, Tianyao Lei, Tianwei Xu, Yijiang Chen & Zhaoxia Wang. (2022) HEY1-mediated cisplatin resistance in lung adenocarcinoma via epithelial–mesenchymal transition. Medical Oncology 40:1.
Crossref
Crossref
Ailing Gu & Xudong Bao. (2022) MiR-99a-5p Constrains Epithelial–Mesenchymal Transition of Cervical Squamous Cell Carcinoma Via Targeting CDC25A/IL6. Molecular Biotechnology 64:11, pages 1234-1243.
Crossref
Crossref
Ke-Da Yang, Ying Wang, Fan Zhang, Qing-Ling Li, Bai-Hua Luo, De-Yun Feng & Zhi-Jun Zeng. (2022) CAF-derived midkine promotes EMT and cisplatin resistance by upregulating lncRNA ST7-AS1 in gastric cancer. Molecular and Cellular Biochemistry 477:11, pages 2493-2505.
Crossref
Crossref
Ludi Yang, Ruobing Jia, Tongxin Ge, Shengfang Ge, Ai Zhuang, Peiwei Chai & Xianqun Fan. (2022) Extrachromosomal circular DNA: biogenesis, structure, functions and diseases. Signal Transduction and Targeted Therapy 7:1.
Crossref
Crossref
Jing TianZe LiYuanyuan JiangWenjin GuEnqi KongQuan HaoBeihua KongLi Sun. (2022)
Downregulation of
SOX21-AS1
Alleviated Cisplatin Resistance in Cervical Cancer Through Epithelial–Mesenchymal Transition Inhibition
. Rejuvenation Research 25:5, pages 243-252.
Crossref
Crossref
Jing Hao, Haimei Liu, Jiawen Wang, Xiuzhen Wang, Chunxia Huang, Lijuan Liang, Jing Chen, Yi Wang & Yunjun Liu. (2022) Iridium (III) complexes induce cervical carcinoma apoptosis via disturbing cellular redox homeostasis disorder and inhibiting PI3K/AKT/mTOR pathway. Journal of Inorganic Biochemistry 235, pages 111946.
Crossref
Crossref
Hong-Tao Li, Liya Xu, Daniel J. Weisenberger, Meng Li, Wanding Zhou, Chen-Ching Peng, Kevin Stachelek, David Cobrinik, Gangning Liang & Jesse L. Berry. (2022) Characterizing DNA methylation signatures of retinoblastoma using aqueous humor liquid biopsy. Nature Communications 13:1.
Crossref
Crossref
Tatsuya Shimada, Yohsuke Yabuki, Takuya Noguchi, Mei Tsuchida, Ryuto Komatsu, Shuhei Hamano, Mayuka Yamada, Yusuke Ezaki, Yusuke Hirata & Atsushi Matsuzawa. (2022) The Distinct Roles of LKB1 and AMPK in p53-Dependent Apoptosis Induced by Cisplatin. International Journal of Molecular Sciences 23:17, pages 10064.
Crossref
Crossref
Jing Tian, Lei Cheng, Enqi Kong, Wenjin Gu, Yuanyuan Jiang, Quan Hao, Beihua Kong & Li Sun. (2022) linc00958/miR-185-5p/RSF-1 modulates cisplatin resistance and angiogenesis through AKT1/GSK3β/VEGFA pathway in cervical cancer. Reproductive Biology and Endocrinology 20:1.
Crossref
Crossref
Lei Deng, Ziyu Fan, Hanlin Xu & Song Yu. (2022) PDSM-LGCN: Prediction of drug sensitivity associated microRNAs via light graph convolution neural network. Methods 205, pages 106-113.
Crossref
Crossref
Ranmali Ranasinghe, Michael L. Mathai & Anthony Zulli. (2022) Cisplatin for cancer therapy and overcoming chemoresistance. Heliyon 8:9, pages e10608.
Crossref
Crossref
Toru Sugiyama, Noriyuki Katsumata, Takafumi Toita, Masako Ura, Ayaka Shimizu, Shuichi Kamijima & Daisuke Aoki. (2022) Incidence of fistula occurrence in patients with cervical cancer treated with bevacizumab: data from real-world clinical practice. International Journal of Clinical Oncology 27:9, pages 1517-1528.
Crossref
Crossref
Lin Qi, Ning Li, Aimin Lin, Xiuli Wang & Jianglin Cong. (2022) Efficacy and safety of pembrolizumab on cervical cancer: A systematic review and single-arm meta-analysis. Frontiers in Oncology 12.
Crossref
Crossref
Rebecca Gupte, Ken Y. Lin, Tulip Nandu, Jayanthi S. Lea & W. Lee Kraus. (2022) Combinatorial Treatment with PARP-1 Inhibitors and Cisplatin Attenuates Cervical Cancer Growth through Fos-Driven Changes in Gene Expression. Molecular Cancer Research 20:8, pages 1183-1192.
Crossref
Crossref
Zheng Zhang, Qiangsheng Hu, Shuang Ye & Libing Xiang. (2022) Inhibition of the PIN1-NRF2/GPX4 axis imparts sensitivity to cisplatin in cervical cancer cells. Acta Biochimica et Biophysica Sinica.
Crossref
Crossref
Jing Chen, Sheng Wu, Jue Wang, Yu Sha & Yong Ji. (2022) Hsa_circ_0074269-mediated Upregulation of TUFT1 Through miR-485-5p Increases Cisplatin Resistance in Cervical Cancer. Reproductive Sciences 29:8, pages 2236-2250.
Crossref
Crossref
Peng Wu, Jing Qin, Lingyan Liu, Wupeng Tan, Linchen Lei & Jiayu Zhu. (2022) circEPSTI1 promotes tumor progression and cisplatin resistance via upregulating MSH2 in cervical cancer. Aging 14:13, pages 5406-5416.
Crossref
Crossref
Nan Zhou, Yan Cui, Rui Zhu, Yuhuan Kuang, Wenhui Ma, Jianyuan Hou, Yumeng Zhu, Shubo Chen, Xin Xu, Ke Tan, Pengxiu Cao, Xianglin Duan & Yumei Fan. (2022) Deferasirox shows inhibition activity against cervical cancer in vitro and in vivo. Gynecologic Oncology 166:1, pages 126-137.
Crossref
Crossref
Qianwen Li, Ming Zhu, Yao Li, Huan Tang, Zeng Wang, Yan Zhang, Yizhuo Xie, Zhe Lv, Han Bao, Yan Li, Rui Liu, Yujia Shen, Yucui Zheng, Dongfanghui Miao, Xin Guo & Jin Pei. (2022) Estrone-targeted PEGylated Liposomal Nanoparticles for Cisplatin (DDP) Delivery in Cervical Cancer. European Journal of Pharmaceutical Sciences 174, pages 106187.
Crossref
Crossref
Yanjun Qu, Hong Zhu, Congcong Kong, Xin Zheng, Dejun Wang, Xiuwei Chen & Dandan Yuan. (2022) RNA modification “writer”-mediated RNA modification patterns and tumor microenvironment characteristics of cervical cancer. Clinical and Translational Oncology 24:7, pages 1413-1424.
Crossref
Crossref
Zhijie Mao, Liyan Zhong, Xiaodan Zhuang, Haoen Liu & Yan Peng. (2022) Curcumenol Targeting YWHAG Inhibits the Pentose Phosphate Pathway and Enhances Antitumor Effects of Cisplatin. Evidence-Based Complementary and Alternative Medicine 2022, pages 1-12.
Crossref
Crossref
Ottavia D’Oria, Giacomo Corrado, Antonio Simone Laganà, Vito Chiantera, Enrico Vizza & Andrea Giannini. (2022) New Advances in Cervical Cancer: From Bench to Bedside. International Journal of Environmental Research and Public Health 19:12, pages 7094.
Crossref
Crossref
Juan Wang, Mengjie Huangfu, Xiaojuan Li, Mengjie Han, Guoxiang Liu, Dan Yu, Luwei Zhou, Tong Dou, Yisa Liu, Xiao Guan, Riming Wei & Xu Chen. (2022) Osthole Induces Apoptosis and Caspase-3/GSDME-Dependent Pyroptosis via NQO1-Mediated ROS Generation in HeLa Cells. Oxidative Medicine and Cellular Longevity 2022, pages 1-22.
Crossref
Crossref
Carly A. Burmeister, Saif F. Khan, Georgia Schäfer, Nomonde Mbatani, Tracey Adams, Jennifer Moodley & Sharon Prince. (2022) Cervical cancer therapies: Current challenges and future perspectives. Tumour Virus Research 13, pages 200238.
Crossref
Crossref
Diego Alem, Lucía Canclini, Susana Castro-Sowinski & Wilner Martínez-López. (2022) Chemosensitizer Effect of Violacein on Cisplatin-treated Bladder Cancer Cells. Clinical Complementary Medicine and Pharmacology 2:2, pages 100036.
Crossref
Crossref
Riccardo Di Fiore, Sherif Suleiman, Rosa Drago-Ferrante, Yashwanth Subbannayya, Francesca Pentimalli, Antonio Giordano & Jean Calleja-Agius. (2022) Cancer Stem Cells and Their Possible Implications in Cervical Cancer: A Short Review. International Journal of Molecular Sciences 23:9, pages 5167.
Crossref
Crossref
Fernando Martínez-Esquivias, Melva Gutiérrez-Angulo, Alejandro Pérez-Larios, Jorge Alberto Sánchez-Burgos, Julieta Sarai Becerra-Ruiz & Juan Manuel Guzmán-Flores. (2022) Anticancer Activity of Selenium Nanoparticles In Vitro Studies. Anti-Cancer Agents in Medicinal Chemistry 22:9, pages 1658-1673.
Crossref
Crossref
Zahra Shakoori, Roghiyeh Pashaei-Asl, Maryam Pashaiasl, Soodabeh Davaran, Hossein Ghanbari, Esmaeil Ebrahimie & Seyed Mahdi Rezayat. (2022) Biocompatibility study of P (N-isopropylacrylamide)-based nanocomposite and its cytotoxic effect on HeLa cells as a drug delivery system for Cisplatin. Journal of Drug Delivery Science and Technology 71, pages 103254.
Crossref
Crossref
Pasumarthi Deepti, Akbar Pasha, Divya Vishambhar Kumbhakar, Ravinder Doneti, S.K. Heena, Shivaji Bhanoth, Pavan Kumar Poleboyina, Rajesh Yadala, Annapurna S.D. & Smita C. Pawar. (2022) Overexpression of Secreted Phosphoprotein 1 (SPP1) predicts poor survival in HPV positive cervical cancer. Gene 824, pages 146381.
Crossref
Crossref
Elizabeth Mahapatra, Debomita Sengupta, Ravindra Kumar, Budheswar Dehury, Salini Das, Madhumita Roy & Sutapa Mukherjee. (2022) Phenethylisothiocyanate Potentiates Platinum Therapy by Reversing Cisplatin Resistance in Cervical Cancer. Frontiers in Pharmacology 13.
Crossref
Crossref
Zhuo Wang, Bao-Sheng Sun, Zhi-Shen Chen, Kang-Kang Zhao, Yun-Long Wang, Fan-Xu Meng & Yang Zhang. (2022) FOXA1 Leads to Aberrant Expression of SIX4 Affecting Cervical Cancer Cell Growth and Chemoresistance. Analytical Cellular Pathology 2022, pages 1-18.
Crossref
Crossref
Manasa Anipindi, Ryan J. Smith & Madiha Gilani. (2022) Case Report: Immune Checkpoint Inhibitors as a Single Agent in the Treatment of Metastatic Cervical Cancer. Frontiers in Oncology 12.
Crossref
Crossref
Jinling Zhou, Yuanhe Wang, Lizhu Zhang, Qin Chen, Xiaojun Zhu, Peiyue Jiang, Nan Jiang, Wei Zhao & Baohua Li. (2022) Engineered Exosomes-Mediated Transfer of hsa-miR-320a Overcomes Chemoresistance in Cervical Cancer Cells via Targeting MCL1. Frontiers in Pharmacology 13.
Crossref
Crossref
Suchitra Mohanty, Poonam Yadav, Harini Lakshminarayanan, Priyanshu Sharma, Aravindhan Vivekanandhan & Devarajan Karunagaran. (2022) RETRA induces necroptosis in cervical cancer cells through RIPK1, RIPK3, MLKL and increased ROS production. European Journal of Pharmacology 920, pages 174840.
Crossref
Crossref
Vahideh Keyvani, Espanta Riahi, Meysam Yousefi, Seyed-Alireza Esmaeili, Rana Shafabakhsh, Amin Moradi Hasan-Abad, Maryam Mahjoubin-Tehran, Michael R. Hamblin, Samaneh Mollazadeh & Hamed Mirzaei. (2022) Gynecologic Cancer, Cancer Stem Cells, and Possible Targeted Therapies. Frontiers in Pharmacology 13.
Crossref
Crossref
Yang Shi, Jigang Chen, Bo Shi & Aihua Liu. (2022) Cost-effectiveness analysis of pembrolizumab for treatment of US patients with persistent, recurrent, or metastatic cervical cancer. Gynecologic Oncology 164:2, pages 379-385.
Crossref
Crossref
Jiang Yang, Mei Yang, Huabing Lv, Min Zhou, Xiaogang Mao, Xiaomin Qin, Ying Xu, Lin Li & Hui Xing. (2022) lncRNA SNHG15 Induced by SOX12 Promotes the Tumorigenic Properties and Chemoresistance in Cervical Cancer via the miR-4735-3p/HIF1a Pathway. Oxidative Medicine and Cellular Longevity 2022, pages 1-15.
Crossref
Crossref
冉浠 张. (2022) Effects of Endoplasmic Reticulum Stress Response on Tumorigenesis and Progression. Advances in Clinical Medicine 12:06, pages 5350-5355.
Crossref
Crossref
Dan Sun, Rui Cao, Lu Han, Xiaohui Yu, Huali Wang, Xiuying Wang & Xuelian Chen. (2022) Long Noncoding RNA Brain Cytoplasmic RNA 1 Induces Cisplatin-Resistance of Cervical Cancer Cells by Sponging MicroRNA-330-5p and Upregulating High-Mobility Group Box 3. Gynecologic and Obstetric Investigation 87:3-4, pages 200-210.
Crossref
Crossref
Yuan Liu, Runsheng Zhao, Xiaomin Qin, Xiaogang Mao, Quan Li & Shanshan Fang. (2022) Cobimetinib Sensitizes Cervical Cancer to Paclitaxel via Suppressing Paclitaxel-Induced ERK Activation. Pharmacology 107:7-8, pages 398-405.
Crossref
Crossref
Zhaoxia Wang, Fengyan Li, Simin He, Le Zhao & Fuyuan Wang. (2022) Period circadian regulator 2 suppresses drug resistance to cisplatin by PI3K/AKT pathway and improves chronochemotherapeutic efficacy in cervical cancer. Gene 809, pages 146003.
Crossref
Crossref
Pushkal Sinduvadi Ramesh, Sharanya Raja, Shwethambari Harave Udayakumar, Shruthi Chandrashekar, Suma M. Nataraj & Devananda Devegowda. (2021) Role of NRF2 cascade in determining the differential response of cervical cancer cells to anticancer drugs: an in vitro study. Molecular Biology Reports 49:1, pages 109-119.
Crossref
Crossref
Chaofan Xie, Wei Xiang, Huiyong Shen & Jingnan Shen. (2021) GTSE1 is possibly involved in the DNA damage repair and cisplatin resistance in osteosarcoma. Journal of Orthopaedic Surgery and Research 16:1.
Crossref
Crossref
Jihui Gu, Yi Liu, Ting Qi, Weiwei Qian, Dongdong Hu & Wen Feng. (2021) Long non-coding RNA DUXAP8 elevates RCN2 expression and facilitates cell malignant behaviors and angiogenesis in cervical cancer via sponging miR-1297. Diagnostic Pathology 16:1.
Crossref
Crossref
Huimin Lv, Shanshan Jin, Binbin Zou, Yuxiang Liang, Jun Xie & Suhui Wu. (2021) Analyzing the whole-transcriptome profiles of ncRNAs and predicting the competing endogenous RNA networks in cervical cancer cell lines with cisplatin resistance. Cancer Cell International 21:1.
Crossref
Crossref
Tandrima Mitra & Selvakumar Elangovan. (2021) Cervical cancer development, chemoresistance, and therapy: a snapshot of involvement of microRNA. Molecular and Cellular Biochemistry 476:12, pages 4363-4385.
Crossref
Crossref
Sabreen Amar, Amr Helmy Mustafa El-Bolok, Sherif Farouk El-Gayar & Maii Ibrahim Sholkamy. (2021) Synergistic Cytotoxic Effect of Honey Bee Venom and Cisplatin on Tongue Squamous Cell Carcinoma Cell Line. Open Access Macedonian Journal of Medical Sciences 9:B, pages 1739-1744.
Crossref
Crossref
Kang Lee, Suji Baek, Myeong Yoon, Ji Park, Bok Hong, Sang Lee, Seung Oh, Seung Kwon, Ruda Lee, Dae Lee, Kang-Seo Park & Byung Moon. (2021) Potential anticancer effect of aspirin and 2'‑hydroxy‑2,3,5'‑trimethoxychalcone‑linked polymeric micelles against cervical cancer through apoptosis. Oncology Letters 23:1.
Crossref
Crossref
Elizabeth Mahapatra, Salini Das, Souvick Biswas, Archismaan Ghosh, Debomita Sengupta, Madhumita Roy & Sutapa Mukherjee. 2021. Cervical Cancer - A Global Public Health Treatise. Cervical Cancer - A Global Public Health Treatise.
Hui He, Cui Zheng & Yunxian Tang. (2021) Overexpression of SMC4 predicts a poor prognosis in cervical cancer and facilitates cancer cell malignancy phenotype by activating NF-κB pathway. Human Cell 34:6, pages 1888-1898.
Crossref
Crossref
Hui Hou, Rong Yu, Haiping Zhao, Hao Yang, Yuchong Hu, Yue Hu & Junmei Guo. (2021) LncRNA OTUD6B-AS1 Induces Cisplatin Resistance in Cervical Cancer Cells Through Up-Regulating Cyclin D2 via miR-206. Frontiers in Oncology 11.
Crossref
Crossref
Anuka SharmaHarmandeep KaurRenaissa DeRadhika SrinivasanArnab PalShalmoli Bhattacharyya. (2021) Knockdown of E-cadherin induces cancer stem-cell-like phenotype and drug resistance in cervical cancer cells. Biochemistry and Cell Biology 99:5, pages 587-595.
Crossref
Crossref
Xin-Tian Zhang, Jing Hu, Li-Hua Su, Chang-An Geng & Ji-Jun Chen. (2021) Artematrolide A inhibited cervical cancer cell proliferation via ROS/ERK/mTOR pathway and metabolic shift. Phytomedicine 91, pages 153707.
Crossref
Crossref
Harsimran Sidhu & Neena Capalash. (2021) Synergistic anti-cancer action of salicylic acid and cisplatin on HeLa cells elucidated by network pharmacology and in vitro analysis. Life Sciences 282, pages 119802.
Crossref
Crossref
Zhiyi Fei, Li Qin, Fang Luo & Yi Yu. (2021) CircRNA circ-ATAD1 Is Upregulated in Cervical Squamous Cell Carcinoma and Regulates Cell Proliferation and Apoptosis by Suppressing the Maturation of miR-218. Reproductive Sciences 28:10, pages 2982-2988.
Crossref
Crossref
Yuzo Sato, Masaru Tomita, Tomoyoshi Soga, Atsushi Ochiai & Hideki Makinoshima. (2021) Upregulation of Thymidylate Synthase Induces Pemetrexed Resistance in Malignant Pleural Mesothelioma. Frontiers in Pharmacology 12.
Crossref
Crossref
Lizhen Gao, Jia Lv, Linlin Hou, Yuchao Yuan & Qiuhua Wan. (2021) Clinical Effects of Chinese Herbal Decoction Combined with Basic Chemoradiotherapy and Nursing Intervention in the Treatment of Cervical Cancer and the Effect on Serum CEA, CA125, and TNF-α Levels. Evidence-Based Complementary and Alternative Medicine 2021, pages 1-7.
Crossref
Crossref
Chihiro Tanaka, Takuro Kobori, Mayuka Tameishi, Yoko Urashima, Takuya Ito & Tokio Obata. (2021) Ezrin Modulates the Cell Surface Expression of Programmed Cell Death Ligand-1 in Human Cervical Adenocarcinoma Cells. Molecules 26:18, pages 5648.
Crossref
Crossref
Suqin Wang, Lina Xu, Zhiqiang Zhang, Ping Wang, Rong Zhang, Hui He & Ling Chen. (2021) Overexpressed miR-375-Loaded Restrains Development of Cervical Cancer Through Down-Regulation of Frizzled Class Receptor 4 (FZD4) with Liposome Nanoparticle as a Carrier. Journal of Biomedical Nanotechnology 17:9, pages 1882-1889.
Crossref
Crossref
Anna Stejskalová, Hugo Vankelecom, Marina Sourouni, Magdalene Y Ho, Martin Götte & Benjamin D Almquist. (2021) In vitro modelling of the physiological and diseased female reproductive system. Acta Biomaterialia 132, pages 288-312.
Crossref
Crossref
Mingyuan Zou, Yue Du, Ruizhen Liu, Zeliang Zheng & Jian Xu. (2021)
Nanocarrier‐delivered small interfering
RNA
for chemoresistant ovarian cancer therapy
. WIREs RNA 12:5.
Crossref
Crossref
Tianzhu Sun, Dengyang Zhang, Zehao Wang, Bingyu Zhao, Yaping Li, Xiuli Sun, Jia Liu, Xuanjun Wang & Jun Sheng. (2021) Inhibition of the notch signaling pathway overcomes resistance of cervical cancer cells to paclitaxel through retardation of the epithelial–mesenchymal transition process. Environmental Toxicology 36:9, pages 1758-1764.
Crossref
Crossref
Jingmiao Wang, Haizhong Zhang, Xiaoyan Yin & Yanrui Bian. (2021) Anti-CD47 antibody synergizes with cisplatin against laryngeal cancer by enhancing phagocytic ability of macrophages. Clinical and Experimental Immunology 205:3, pages 333-342.
Crossref
Crossref
Mohamed El‐Mesery, Axel Seher, Mohamed El‐Shafey, Mohamed El‐Dosoky & Farid A Badria. (2020) Repurposing of quinoline alkaloids identifies their ability to enhance doxorubicin‐induced sub‐G0/G1 phase cell cycle arrest and apoptosis in cervical and hepatocellular carcinoma cells. Biotechnology and Applied Biochemistry 68:4, pages 832-840.
Crossref
Crossref
Lei Liu, Min Wang, Xianping Li, Sheng Yin & Bingqi Wang. (2021) An Overview of Novel Agents for Cervical Cancer Treatment by Inducing Apoptosis: Emerging Drugs Ongoing Clinical Trials and Preclinical Studies. Frontiers in Medicine 8.
Crossref
Crossref
Tao Liu, Rongmu Xia, Chenmeng Li, Xiaocong Chen, Xuemin Cai & Wengang Li. (2021)
mRNA expression level of
CDH2, LEP, POSTN, TIMP1
and
VEGFC
modulates 5‑fluorouracil resistance in colon cancer cells
. Experimental and Therapeutic Medicine 22:3.
Crossref
Crossref
Eui-Baek Byun, Ha-Yeon Song, Woo Sik Kim, Jeong Moo Han, Ho Seong Seo, Sang-Hyun Park, Kwangwook Kim & Eui-Hong Byun. (2021) Protective Effect of Polysaccharides Extracted from Cudrania tricuspidata Fruit against Cisplatin-Induced Cytotoxicity in Macrophages and a Mouse Model. International Journal of Molecular Sciences 22:14, pages 7512.
Crossref
Crossref
Jenna M. Len, Noor Hussein, Saloni Malla, Kyle Mcintosh, Rahul Patidar, Manivannan Elangovan, Karthikeyan Chandrabose, N. S. Hari Narayana Moorthy, Manoj Pandey, Dayanidhi Raman, Piyush Trivedi & Amit K. Tiwari. (2021) A Novel Dialkylamino-Functionalized Chalcone, DML6, Inhibits Cervical Cancer Cell Proliferation, In Vitro, via Induction of Oxidative Stress, Intrinsic Apoptosis and Mitotic Catastrophe. Molecules 26:14, pages 4214.
Crossref
Crossref
Dongyuan Jiang, Chenchen Ren, Li Yang, Feiyan Li, Xin Yang, Yating Zheng, Xiaoying Ji & Yue Tian. (2021)
Williams syndrome transcription factor promotes proliferation and invasion of cervical cancer cells by regulating
PI3K
/Akt signaling pathway
. Journal of Obstetrics and Gynaecology Research 47:7, pages 2433-2441.
Crossref
Crossref
Mardi M. Algandaby. (2021) Quercetin attenuates cisplatin-induced ovarian toxicity in rats: Emphasis on anti-oxidant, anti-inflammatory and anti-apoptotic activities. Arabian Journal of Chemistry 14:7, pages 103191.
Crossref
Crossref
Pariyakorn Udomwan, Chamsai Pientong, Panwad Tongchai, Ati Burassakarn, Nuchsupha Sunthamala, Sittiruk Roytrakul, Supawadee Suebsasana & Tipaya Ekalaksananan. (2021) Proteomics Analysis of Andrographolide-Induced Apoptosis via the Regulation of Tumor Suppressor p53 Proteolysis in Cervical Cancer-Derived Human Papillomavirus 16-Positive Cell Lines. International Journal of Molecular Sciences 22:13, pages 6806.
Crossref
Crossref
Lina Wang, Zejun Liu, Shumei He, Shasha He & Yupeng Wang. (2021) Fighting against drug-resistant tumors by the inhibition of γ-glutamyl transferase with supramolecular platinum prodrug nano-assemblies. Journal of Materials Chemistry B 9:22, pages 4587-4595.
Crossref
Crossref
Ya-Hui Chen, Po-Hui Wang, Pei-Ni Chen, Shun-Fa Yang & Yi-Hsuan Hsiao. (2021) Molecular and Cellular Mechanisms of Metformin in Cervical Cancer. Cancers 13:11, pages 2545.
Crossref
Crossref
Zhimin Tang, Nan Tang, Shanshan Jiang, Yangjinming Bai, Chenxi Guan, Wansi Zhang, Shipan Fan, Yonghong Huang, Hui Lin & Ying Ying. (2021) The Chemosensitizing Role of Metformin in Anti-Cancer Therapy. Anti-Cancer Agents in Medicinal Chemistry 21:8, pages 949-962.
Crossref
Crossref
Hassan Noorbazargan, Sobhan Amintehrani, Aghigh Dolatabadi, Ainaz Mashayekhi, Nazanin Khayam, Pooria Moulavi, Mohammad Naghizadeh, Amir Mirzaie, Fatmeh Mirzaei rad & Mahsa Kavousi. (2021) Anti-cancer & anti-metastasis properties of bioorganic-capped silver nanoparticles fabricated from Juniperus chinensis extract against lung cancer cells. AMB Express 11:1.
Crossref
Crossref
Jing Ke, Chunming Gu, Heyan Zhang, Yang Liu, Wenhao Zhang, Huiling Rao, Shan Li & Fuyun Wu. (2021) Nucleolin Promotes Cisplatin Resistance in Cervical Cancer by the YB1-MDR1 Pathway. Journal of Oncology 2021, pages 1-11.
Crossref
Crossref
Hanlin Ma, Fang Han, Xiaohui Yan, Gonghua Qi, Yingwei Li, Rongrong Li, Shi Yan, Cunzhong Yuan, Kun Song & Beihua Kong. (2020) PBK promotes aggressive phenotypes of cervical cancer through ERK/c‐Myc signaling pathway. Journal of Cellular Physiology 236:4, pages 2767-2781.
Crossref
Crossref
Rina Masadah, Syahrul Rauf, Muhammad Yogi Pratama, Claudio Tiribelli & Devis Pascut. (2021) The Role of microRNAs in the Cisplatin- and Radio-Resistance of Cervical Cancer. Cancers 13:5, pages 1168.
Crossref
Crossref
Tjalling Bosse, Sigurd Lax, Nadeem Abu-Rustum & Xavier Matias-Guiu. (2021) The Role of Predictive Biomarkers in Endocervical Adenocarcinoma: Recommendations From the International Society of Gynecological Pathologists. International Journal of Gynecological Pathology 40:Supplement 1, pages S102-S110.
Crossref
Crossref
Wenming Cui, Qin Dang, Chen Chen, Weitang Yuan & Zhenqiang Sun. (2021) Roles of circRNAs on tumor autophagy. Molecular Therapy - Nucleic Acids 23, pages 918-929.
Crossref
Crossref
Wenshuang Wang, Anli Xu, Manyin Zhao, Jianan Sun & Lingyun Gao. (2021) Circ_0001247 functions as a miR-1270 sponge to accelerate cervical cancer progression by up-regulating ZEB2 expression level. Biotechnology Letters 43:3, pages 745-755.
Crossref
Crossref
Yuan Liu, Runsheng Zhao, Shanshan Fang, Quan Li, Yiqiang Jin & Bo Liu. (2020) Abemaciclib sensitizes HPV‐negative cervical cancer to chemotherapy via specifically suppressing CDK4/6‐Rb‐E2F and mTOR pathways. Fundamental & Clinical Pharmacology 35:1, pages 156-164.
Crossref
Crossref
Chunyan Jia, Glen B. Deacon, Yingjie Zhang & Chuanzhu Gao. (2021) Platinum(IV) antitumor complexes and their nano-drug delivery. Coordination Chemistry Reviews 429, pages 213640.
Crossref
Crossref
Chao Wu, Lei Chen, Haitao Tao, Lu Kong & Yi Hu. (2020) RING finger protein 38 induces the drug resistance of cisplatin in non‐small‐cell lung cancer. Cell Biology International 45:2, pages 287-294.
Crossref
Crossref
爱敏 王. (2021) Research Progress on the Mechanism of Tumor Drug Resistance. Advances in Clinical Medicine 11:12, pages 6139-6142.
Crossref
Crossref
Zhuanghua Li, Shaowen Li, Yongqin Wen, Jingtang Chen, Kejun Liu & Jun Jia. (2021) MiR-495 Inhibits Cisplatin Resistance and Angiogenesis in Esophageal Cancer by Targeting ATP7A. Technology in Cancer Research & Treatment 20, pages 153303382110391.
Crossref
Crossref
Oswaldo Pablo Martínez-Rodríguez, Alejandro González-Torres, Luis Marat Álvarez-Salas, Humberto Hernández-Sánchez, Blanca Estela García-Pérez, María del Rocío Thompson-Bonilla & María Eugenia Jaramillo-Flores. (2021) Effect of naringenin and its combination with cisplatin in cell death, proliferation and invasion of cervical cancer spheroids. RSC Advances 11:1, pages 129-141.
Crossref
Crossref
Maya Nair, Lorna A. Brudie, Vikas Venkata Mudgapalli, V. Gayathri, Anjali Chandra, Sarfraz Ahmad & Riyaz Basha. 2021. Overcoming Drug Resistance in Gynecologic Cancers. Overcoming Drug Resistance in Gynecologic Cancers
127
154
.
Anum Jalil, James Wert, Aimen Farooq & Sarfraz Ahmad. 2021. Overcoming Drug Resistance in Gynecologic Cancers. Overcoming Drug Resistance in Gynecologic Cancers
195
205
.
Luna Acharya, Hariharasudan Mani, Aman Ullah, Sana Hussain, Saeed Ali & Sarfraz Ahmad. 2021. Overcoming Drug Resistance in Gynecologic Cancers. Overcoming Drug Resistance in Gynecologic Cancers
49
75
.
Huanran Sun, Jiaqi Song, Mingming Sun & Changliang Shan. 2021. Epigenetic Regulation in Overcoming Chemoresistance. Epigenetic Regulation in Overcoming Chemoresistance
25
39
.
S. Sumathi, K. Santhiya & J. Sivaprabha. 2021. A Theranostic and Precision Medicine Approach for Female-Specific Cancers. A Theranostic and Precision Medicine Approach for Female-Specific Cancers
49
69
.
Malgorzata Tyszka-Czochara. 2021. Cancer. Cancer
281
290
.
Margaretha A. Skowron, Michèle J. Hoffmann, Meike M. Watolla & Daniel Nettersheim. 2021. Testicular Germ Cell Tumors. Testicular Germ Cell Tumors
99
111
.
Sajjad Makhdoomi, Akram Oftade, Sodabe Khodabandehlou & Akram Ranjbar. (2020) Pulmonary Protective Effects of Propofol on Cisplatin-Induced Oxidative Damage in Male Rats. Avicenna Journal of Pharmaceutical Research 1:2, pages 72-75.
Crossref
Crossref
Sebastian O. Wendel, Jazmine A. Snow, Tyler Bastian, Laura Brown, Candy Hernandez, Emily Burghardt, Andrew Kahn, Vaibhav Murthy, Daniel Neill, Zachary C. Smith, Kevin Ault, Ossama Tawfik, Cen Wu & Nicholas A. Wallace. (2020) High Risk α-HPV E6 Impairs Translesion Synthesis by Blocking POLη Induction. Cancers 13:1, pages 28.
Crossref
Crossref
Alejandro Bravo-Cuellar, Pablo Cesar Ortiz-Lazareno, Erick Sierra-Díaz, Fabiola Solorzano-Ibarra, Anibal Samael Méndez-Clemente, Adriana Aguilar-Lemarroy, Luis Felipe Jave-Suárez, Édgar Ruiz Velazco-Niño & Georgina Hernández-Flores. (2020) Pentoxifylline Sensitizes Cisplatin-Resistant Human Cervical Cancer Cells to Cisplatin Treatment: Involvement of Mitochondrial and NF-Kappa B Pathways. Frontiers in Oncology 10.
Crossref
Crossref
Linhan Zhuang, Regina Ly, Frank Rösl & Martina Niebler. (2020) p53 Is Regulated in a Biphasic Manner in Hypoxic Human Papillomavirus Type 16 (HPV16)-Positive Cervical Cancer Cells. International Journal of Molecular Sciences 21:24, pages 9533.
Crossref
Crossref
Xiaoling Wu, Youwen Zhong, Qing Chen, Xin Zhang & Hua Zhang. (2020) Enhancer of mRNA Decapping protein 4 (EDC4) interacts with replication protein a (RPA) and contributes to Cisplatin resistance in cervical Cancer by alleviating DNA damage. Hereditas 157:1.
Crossref
Crossref
Yihong Chen, Qiumei Wu, Jing Lin & Juanbing Wei. (2020) DARS-AS1 accelerates the proliferation of cervical cancer cells via miR-628-5p/JAG1 axis to activate Notch pathway. Cancer Cell International 20:1.
Crossref
Crossref
Lian Gong, Yi Hu, Dong He, Yuxing Zhu, Liang Xiang, Mengqing Xiao, Ying Bao, Xiaoming Liu, Qinghai Zeng, Jianye Liu, Ming Zhou, Yanhong Zhou, Yaxin Cheng, Yeyu Zhang, Liping Deng, Rongrong Zhu, Hua Lan & Ke Cao. (2020) Ubiquitin ligase CHAF1B induces cisplatin resistance in lung adenocarcinoma by promoting NCOR2 degradation. Cancer Cell International 20:1.
Crossref
Crossref
Maria Luiza Tabosa de Carvalho Galvão & Eliane Campos Coimbra. (2020) Long noncoding RNAs (lncRNAs) in cervical carcinogenesis: New molecular targets, current prospects. Critical Reviews in Oncology/Hematology 156, pages 103111.
Crossref
Crossref
Le He, Jiaxi Xu, Xu Cheng, Min Sun, Bing Wei, Nanchi Xiong, Jiayu Song, Xin Wang & Rupei Tang. (2020) Hybrid micelles based on Pt (IV) polymeric prodrug and TPGS for the enhanced cytotoxicity in drug-resistant lung cancer cells. Colloids and Surfaces B: Biointerfaces 195, pages 111256.
Crossref
Crossref
Takahiro Shimizu, Takuto Fujii & Hideki Sakai. (2020) The Relationship Between Actin Cytoskeleton and Membrane Transporters in Cisplatin Resistance of Cancer Cells. Frontiers in Cell and Developmental Biology 8.
Crossref
Crossref
Fabricio Ledezma-Gallegos, Rafael Jurado, Roser Mir, Luis Alberto Medina, Laura Mondragon-Fuentes & Patricia Garcia-Lopez. (2020) Liposomes Co-Encapsulating Cisplatin/Mifepristone Improve the Effect on Cervical Cancer: In Vitro and In Vivo Assessment. Pharmaceutics 12:9, pages 897.
Crossref
Crossref
Midori Murakami, Hiroto Izumi, Tomoko Kurita, Chiho Koi, Yasuo Morimoto & Kiyoshi Yoshino. (2020) UBE2L6 is Involved in Cisplatin Resistance by Regulating the Transcription of ABCB6. Anti-Cancer Agents in Medicinal Chemistry 20:12, pages 1487-1496.
Crossref
Crossref
Ethan L. Morgan & Andrew Macdonald. (2020) Manipulation of JAK/STAT Signalling by High-Risk HPVs: Potential Therapeutic Targets for HPV-Associated Malignancies. Viruses 12:9, pages 977.
Crossref
Crossref
Meng Wang, Chang Liu, Yuehan Li, Qiulin Zhang, Lixia Zhu, Zishui Fang & Lei Jin. (2020) Verteporfin Is a Promising Anti-Tumor Agent for Cervical Carcinoma by Targeting Endoplasmic Reticulum Stress Pathway. Frontiers in Oncology 10.
Crossref
Crossref
Subhajit Chatterjee & Chanakya Nath Kundu. (2020) Nanoformulated quinacrine regulates NECTIN-4 domain specific functions in cervical cancer stem cells. European Journal of Pharmacology 883, pages 173308.
Crossref
Crossref
Hui Ma, Wei Cao & Meili Ding. (2020)
Retracted:
MicroRNA‐31 weakens cisplatin resistance of medulloblastoma cells via NF‐κB and PI3K/AKT pathways
. BioFactors 46:5, pages 831-838.
Crossref
Crossref
Sang Ah Yi, Go Woon Kim, Jung Yoo, Jeung-Whan Han & So Hee Kwon. (2020) HP1γ Sensitizes Cervical Cancer Cells to Cisplatin through the Suppression of UBE2L3. International Journal of Molecular Sciences 21:17, pages 5976.
Crossref
Crossref
Diego Alem, Juan José Marizcurrena, Verónica Saravia, Danilo Davyt, Wilner Martinez-Lopez & Susana Castro-Sowinski. (2020) Production and antiproliferative effect of violacein, a purple pigment produced by an Antarctic bacterial isolate. World Journal of Microbiology and Biotechnology 36:8.
Crossref
Crossref
Jalal Hassanshahi, Afsaneh Mirzahosseini-pourranjbar, Zahra Hajializadeh & Ayat Kaeidi. (2020) Anticancer and cytotoxic effects of troxerutin on HeLa cell line: an in-vitro model of cervical cancer. Molecular Biology Reports 47:8, pages 6135-6142.
Crossref
Crossref
Xingyu Fang, Guanglei Zhong, Yuhan Wang, Zhongqiu Lin, Rongchun Lin & Tingting Yao. (2020) Low GAS5 expression may predict poor survival and cisplatin resistance in cervical cancer. Cell Death & Disease 11:7.
Crossref
Crossref
Xiaoxiao Yang, Mark de Caestecker, Leo E. Otterbein & Binghe Wang. (2019) Carbon monoxide: An emerging therapy for acute kidney injury. Medicinal Research Reviews 40:4, pages 1147-1177.
Crossref
Crossref
Hung‐Ju Chien, Tsung‐Ho Ying, Shu‐Ching Hsieh, Chia‐Liang Lin, Yung‐Luen Yu, Shao‐Hsuan Kao & Yi‐Hsien Hsieh. (2020) α‐Mangostin attenuates stemness and enhances cisplatin‐induced cell death in cervical cancer stem‐like cells through induction of mitochondrial‐mediated apoptosis. Journal of Cellular Physiology 235:7-8, pages 5590-5601.
Crossref
Crossref
Wangjie Yu, Yunyun Chen, Nagireddy Putluri, Cristian Coarfa, Matthew J. Robertson, Vasanta Putluri, Fabio Stossi, Julien Dubrulle, Michael A. Mancini, Jonathan C. Pang, Trung Nguyen, Dodge Baluya, Jeffrey N. Myers, Stephen Y. Lai & Vlad C. Sandulache. (2020) Acquisition of Cisplatin Resistance Shifts Head and Neck Squamous Cell Carcinoma Metabolism toward Neutralization of Oxidative Stress. Cancers 12:6, pages 1670.
Crossref
Crossref
Xingmei LiYuewen LiYuning HanBing DongDan LiuLiqun CheYu LiuYuchun Wang. (2020)
Retracted:
miR-205 Promotes Apoptosis of Cervical Cancer Cells and Enhances Drug Sensitivity of Cisplatin by Inhibiting YAP1
. Cancer Biotherapy and Radiopharmaceuticals 35:5, pages 338-344.
Crossref
Crossref
Rui Tong, Jingru Zhang, Chunyan Wang, Qian Li, Ling Wang & Mingxiu Ju. (2019) Inhibition of miR-574-5p suppresses cell growth and metastasis and enhances chemosensitivity by targeting RNA binding protein QKI in cervical cancer cells. Naunyn-Schmiedeberg's Archives of Pharmacology 393:6, pages 951-966.
Crossref
Crossref
Peter A. Ajibade, Amos A. Fatokun & Fartisincha P. Andrew. (2020) Synthesis, characterization and anti-cancer studies of Mn(II), Cu(II), Zn(II) and Pt(II) dithiocarbamate complexes - crystal structures of the Cu(II) and Pt(II) complexes. Inorganica Chimica Acta 504, pages 119431.
Crossref
Crossref
Hui Huang, Shuyuan Cao, Zhan Zhang, Lei Li, Feng Chen & Qian Wu. (2020) Multiple omics analysis of the protective effects of SFN on estrogen-dependent breast cancer cells. Molecular Biology Reports 47:5, pages 3331-3346.
Crossref
Crossref
Lian Gong, Mengqing Xiao, Dong He, Yi Hu, Yuxing Zhu, Liang Xiang, Ying Bao, Xiaoming Liu, Qinghai Zeng, Jianye Liu, Ming Zhou, Yanhong Zhou, Yaxin Cheng, Yeyu Zhang, Liping Deng, Rongrong Zhu, Hua Lan & Ke Cao. (2020) WDHD1 Leads to Cisplatin Resistance by Promoting MAPRE2 Ubiquitination in Lung Adenocarcinoma. Frontiers in Oncology 10.
Crossref
Crossref
Isabella Giacomini, Veronica Cocetta, Maria Carrara, Eugenio Ragazzi & Monica Montopoli. (2020) Plumbagin Induces Cell Cycle Arrest and Apoptosis in A431 Cisplatin-Resistant Cancer Cells. Natural Product Communications 15:4, pages 1934578X2092162.
Crossref
Crossref
Yiqing Lai, Beibei Zhou, Qingqing Tan, Juan Xu, Ting Wan & Lina Zhang. (2019) LINC00116 enhances cervical cancer tumorigenesis through miR‐106a/c‐Jun pathway. Journal of Cellular Biochemistry 121:3, pages 2247-2257.
Crossref
Crossref
Yufeng Liu, Zhimin Zhang, Liang Zhang & Zhaoyang Zhong. (2020) Cytoplasmic APE1 promotes resistance response in osteosarcoma patients with cisplatin treatment. Cell Biochemistry and Function 38:2, pages 195-203.
Crossref
Crossref
Displaying 200 of 244 citing articles. Use the download link below to view the full list of citing articles.
Download full citations list